DNA flow cytometry of bone metastases of different primary tumors;DNA-flowzytometrie von knochenmetastasen unterschiedlicher primärtumoren

Zeitschrift fur Orthopadie und Ihre Grenzgebiete

Volumn 140, Issue 4, 2002, Pages 440-446

  Wohlrab, David ^a   Reichel, H ^a   Hein, W ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Bone metastasis; Flow cytometry; Ploidy

Indexed keywords

ADULT; AGED; ANEUPLOIDY; ARTICLE; BONE METASTASIS; BREAST CANCER; CELL CYCLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIPLOIDY; DNA CONTENT; DNA DETERMINATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CANCER; LUNG CANCER; MALE; PLOIDY; PROGNOSIS; PROSTATE CANCER; STEM CELL; TUMOR CELL CULTURE; BONE; BONE TUMOR; CELL DIVISION; METASTASIS; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

DNA;

ADULT; AGED; BONE AND BONES; BONE NEOPLASMS; CELL CYCLE; CELL DIVISION; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; PLOIDIES; PROGNOSIS;

EID: 0036628627     PISSN: 00443220     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-33391     Document Type: Article

References (35)

1. Bruns J. Indikationen zur operativen Therapie von peripheren Skelettmetastasen. Reichel H, Hein W (Hrsg.). Maligne Knochentumoren. Berlin: Logos Verlag, 1997: 155-170
2. Koldehoff M. Zellzyklusregulation und die Funktion beim neoplastischen Wachstum. Biol Med 1997; 26: 62-66
3. Büchner T, Hliddemann W, Wörmann B, Kleinemeier B, et al. Differential pattern of DNA aneuploidy in human malignancies. Path Res Pract 1985; 179: 310-317
4. Fiedlander ML, Hedley DW, Taylor IW. Clinical and biological significance of aneuploidy in human tumours. J Cutan Pathol 1984; 37: 961-974
5. Vindelov EL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983; 3: 323-327
6. Otto FJ, Oldiges HH, Gohde W, Jain VK. Flow cytometric measurement of nuclear DNA content variations as a potential in vivo mutagenicity test. Cytometry 1981; 2: 189-191
7. Hiddemann W, Schumahn J, Andreeff M, Barlogie B, Herman CJ, Leif RC, Mayall RF, Murphy RF, Sandberg AA. Convention on nomenclature for DNA cytometry. Cytometry 1984; 5: 445-446
8. Funk JO, Kind P. Zellzykluskontrolle, genetische Stabilität und Krebs. Hautarzt 1997; 48: 157-165
9. Krutmann J, Funk JO, Korge B. Warum metastasieren maligne Tumore organspezifisch? Hautarzt 2001; 52: 475
10. Muller A, Homey B, Soto H, Ge N, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 1-3-2001; 410: 50-56
11. Bauer HC, Wedin R. Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients. Acta Orthop Scand 1995; 66: 143-146
12. Sioutos PJ, Arbit E, Meshulam CF, Galicich JH. Spinal metastases from solid tumors. Analysis of factors affecting survival. Cancer 15-10-1995; 76: 1453-1459
13. Böcking A, Streepecke E, Füzesi L. Zytogenetische und proliferationskinetische Grundlagen der diagnostischen DNA-Zytometrie. Verh Dtsch Ges Path 1994; 78: 552-554
14. Kang HS, Youn YK, Oh SK, Choe KJ, Noh DY. Flow cytometric analysis of primary tumors and their corresponding metastatic nodes in breast cancer. Breast Cancer Res Treat. 2000; 63: 81-87
15. Shalev M, Gdor Y, Leventis A, Radnay J, Shapiro HH, Bernheim J, Nissenkorn I. The prognostic value of DNA ploidy in small renal cell carcinoma. Pathol Res Pract 2001; 197: 7-12
16. Liewald F, Hatz R, Storck M, Orend KH, Weiss M, Wulf G, Valet G, Sunder-Plassmann L. Prognostic value of deoxyribonucleic acid aneuploidy in primary non-small-cell lung carcinomas and their metastases. J Thorac Cardiovasc Surg 1992; 104: 1476-1482
17. Ayabe H, Tomita M, Kawahara K, Tagawa Y, Tsuji H, Akamine S. DNA stemline heterogeneity of non-small cell lung carcinomas and differences in DNA ploidy between carcinomas and metastatic nodes. Lung Cancer 1994; 11: 201-208
18. Clark GM, McGuire WL. New biologic prognostic factors in breast cancer. Oncology (Hluntingt) 1989; 3: 49-54
19. Bartkowiak D, Schumann J, Otto FJ, Lippold A, Drepper H. DNA flow cytometry in the prognosis of primary malignant melanoma. Oncology 1991; 48: 39-43
20. Muhonen T, Pyrhonen S, Laasonen A, Asko-Seljavaara S, Franssila K. DNA aneuploidy and low S-phase fraction as favourable prognostic signs in metastatic melanoma. Br J Cancer 1991; 64: 749-752
21. Karlsson M, Boeryd B, Carstensen J, Kagedal B, Bratel AT, Wingren S. DNA ploidy and S-phase in primary malignant melanoma as prognostic factors for stage III disease. Br J Cancer 1993; 67: 134-138
22. Stanton PD, Cooke TG, Oakes SJ, Winstanley J, Holt S, George WD, Murray GD. Lack of prognostic significance of DNA pfoidy and S-phase fraction in breast cancer. Br J Cancer 1992; 66: 925-929
23. Bosari S, Lee AK, Wiley-BD, Heatley GJ, Silverman ML. Flow cytometric and image analyses of colorectal adenocarcinomas. A comparative study with clinical correlations. Am J Clin Pathol 1993; 99: 187-194
24. Rodenburg CJ, Ploem-Zaaijer JJ, Cornelisse CJ, Mesker WE, Hermans J, Heintz PA, Ploem JS, Fleuren GJ. Use of DNA image cytometry in addition to flow cytometry for the study of patients with advanced ovarian cancer. Cancer Res 1-8-1987; 47: 3938-3941
25. Vogt T, Stolz W, Braun-Falco O, Kaudewitz P, Eckert F, Abmayr W, Dummer R, Burg G. Prognostic significance of DNA cytometry in cutaneous malignant lymphomas. Cancer 1991; 68: 1095-1100
26. Umebayashi Y, Otsuka F. Prognostic significance in malignant melanoma of nuclear DNA content measured by a microfluorimetric method. Arch Dermatol Res 1995; 287: 718-722
27. Zaloudik J, Moore M, Hasleton PS. The DNA content of colorectal carcinomas: an analysis of the heterogeneity of aneuploidy and correlation with immunopathological parameters. Neoplasma 1988; 35: 389-401
28. Lindholm C, Hofer PA, Jonsson H. Single cell DNA cytophotometry in clinical stage 1 malignant melanoma. Relationship to prognosis. Acta Oncol 1990; 29: 147-150
29. Kristensen GB, Kaern J, Abeler VM, Hagmar B, Trope CG, Pettersen EO. No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patients. Gynecol Oncol 1995; 57: 79-85
30. Fasano M, Vamvakas E, Delgado Y, Inghirami G, Mitnick J, Roses D, Feiner H. Tubular Carcinoma of the Breast: Immunohistochemical and DNA Flow Cytometric Profile. Breast J 1999; 5: 252-255
31. Bracko M, Us-Krasovec M, Cufer T, Lamovec J, Zidar A, Goehde W. Prognostic significance of DNA ploidy determined by high-resolution flow cytometry in breast carcinoma. Anal Quant Cytol Histol 2001; 23: 56-66
32. Eskelinen M, Lipponen P, Nordling S. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma. Anticancer Res 1995; 15: 2279-2283
33. Klapperstück T. Methodische Aspekte der DNA-Bildanalyse im Schnitt und Vergleich der Ergebnisse im Ausstrich und der Durchflusszytometrie. Mathematisch Naturwissenschaftlich-Technische Fakultät der Martin-Luther-Universität Halle Wittenberg: Dissertationsschrift, 2001
34. Dorman AM, Walsh TN, Droogan O, Curran B, Hourihane DO, Hennessy TP, Leader M. DNA quantification of squamous cell carcinoma of the oesophagus by flow cytometry and cytophotometric image analysis using formalin fixed paraffin embedded tissue. Cytometry 1992; 13: 886-892
35. Auer G, Askenstein U, Ahrens O. Cytophotometry. Hum Pathol 1989; 20: 518-527